| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Director | Senior VP & COO +2 more
2 companies
Mark Newman last filed a Form 4 in June 2023, as President and CEO at CC. The filings on record cover 2 companies. Mark Newman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Mark Newman a middling insider score of 52/100, based on 5 past trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -3.5%.
At the last filing, the largest reported position was 266,955 shares of CC. The CC filings lean toward selling, a net 376,338 shares.
Mark Newman has 50 Form 4 filings on record from July 2015 to June 2023, across 2 companies: President and CEO at Chemours (CC), 2015–2023; Director at Altria Group (MO), 2018–2021.
The 87 reported transactions were 23 option or other derivative awards, 15 stock awards, 14 tax withholdings and 14 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 6 purchases worth about $1.0M and 9 sales worth about $16.9M.
The largest open-market purchase was 20,000 shares of CC at an average $16.42 on September 11, 2019, about $328K.
The largest open-market sale was 197,161 shares of CC at an average $40.22 on May 5, 2022, about $7.9M. Twelve months later CC was down 24%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | CC Chemours Co | President and CEO | Buy | 7,661 | $34.63 | $265,299.66 | +3.0% | +0.2% | -22.6% | |
| May 5, 2022 | CC Chemours Co | President and CEO | Sale+OE | 197,161 | $40.22 | $7,929,815.42 | -52.8% | -13.0% | -23.9% | |
| Dec 2, 2021 | CC Chemours Co | President and CEO | Sale+OE | 34,252 | $29.94 | $1,025,504.88 | -19.1% | -8.6% | +8.4% | |
| Aug 30, 2021 | CC Chemours Co | President and CEO | Sale+OE | 3,691 | $35.00 | $129,185.00 | -2.5% | -8.0% | +4.3% | |
| Aug 27, 2021 | CC Chemours Co | President and CEO | Sale+OE | 29,732 | $35.00 | $1,040,620.00 | -17.0% | -10.5% | +6.1% | |
| May 7, 2020 | CC Chemours Co | Senior VP & COO | Buy | 2,500 | $11.62 | $29,048.35 | +1.9% | - | - | |
| Sep 11, 2019 | CC Chemours Co | Senior VP & COO | Buy | 20,000 | $16.42 | $328,340.00 | +21.2% | - | - | |
| Mar 11, 2019 | CC Chemours Co | Senior VP and CFO | Sell | 59,210 | $38.26 | $2,265,374.60 | -38.6% | - | - | |
| May 8, 2018 | CC Chemours Co | SVP and CFO | Sale+OE | 43,675 | $50.04 | $2,185,403.75 | -34.8% | - | - | |
| Apr 30, 2018 | MO Altria Group, Inc. | Director | Buy | 5,345 | $56.19 | $300,334.48 | +789.5% | - | - |